Major study of Ivermectin finds 'no effect whatsoever'

by morgengold on 8/12/2021, 9:45:09 AM with 4 comments

  • by smileypete on 8/12/2021, 2:49:53 PM

    The problem of Ivermectin trials based in Latin American countries is that community Ivermectin use is so widespread, it becomes a major confounder in trials because most of the 'placebo' group could be using it.

    'Latin America’s embrace of an unproven COVID treatment is hindering drug trials'

    https://www.nature.com/articles/d41586-020-02958-2

    Hopefully it would be noted in the limitations section of the trial paper, but the writers of media articles are often polarized or biased and just cherry pick.

    ETA, personally I would prefer small well designed trials from researchers with historical expertise who provide plenty of accompanying information and are willing to discuss the results, eg Chaccour et al:

    'The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial'

    https://www.thelancet.com/journals/eclinm/article/PIIS2589-5...

    https://www.youtube.com/watch?v=yIUO08W94eY https://www.youtube.com/watch?v=JuzHG0rpOrc

  • by velcii on 8/12/2021, 11:53:12 AM

    Peter McCullough, MD testifies to Texas Senate HHS Committee

    The part where they talk about trials like these..

    https://www.youtube.com/watch?v=QAHi3lX3oGM&t=958s

    Viewing full testimony is recommended.

  • by christmm on 8/12/2021, 10:34:20 AM

    Why does this report put a large photo of Trump? Why not let the study stand on its own scientific merit?

  • by morgengold on 8/12/2021, 9:45:09 AM

    Ivermectin, the latest supposed treatment for COVID-19 being touted by anti-vaccination groups, had “no effect whatsoever” on the disease, according to a large patient study.

    That’s the conclusion of the Together Trial, which has subjected several purported nonvaccine treatments for COVID-19 to carefully designed clinical testing. The trial is supervised by McMaster University in Hamilton, Canada, and conducted in Brazil ...